| [1] |
He CH, Mansilla-Soto J, Khanra N, et al. CD19 CAR antigen engagement mechanisms and affinity tuning[J]. Sci Immunol, 2023, 8(81):eadf1426.
|
| [2] |
Xiao XY, Huang SK, Chen SF, et al. Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies[J]. J Exp Clin Cancer Res, 2021, 40(1):367.
doi: 10.1186/s13046-021-02148-6
pmid: 34794490
|
| [3] |
Porter DL, Levine BL, Kalos M, et al. Chimeric antigen recep-tor-modified T cells in chronic lymphoid leukemia[J]. N Engl J Med, 2011, 365(8):725-733.
|
| [4] |
Xing XY, Hu XY. Risk factors of cytokine release syndrome:stress,catecholamines,and beyond[J]. Trends Immunol, 2023, 44(2):93-100.
|
| [5] |
Browne EK, Daut E, Hente M, et al. Evidence-based recommen-dations for nurse monitoring and management of immuno-therapy-induced cytokine release syndrome:a systematic review from the children’s oncology group[J]. J Pediatr Oncol Nurs, 2021, 38(6):399-409.
|
| [6] |
Morris EC, Neelapu SS, Giavridis T, et al. Cytokine release syn-drome and associated neurotoxicity in cancer immunotherapy[J]. Nat Rev Immunol, 2022, 22(2):85-96.
|
| [7] |
汤芳, 朱霞明, 陆茵, 等. 多发性骨髓瘤患者行嵌合抗原受体修饰T细胞治疗的护理[J]. 中华护理杂志, 2019, 54(10):1495-1498.
doi: 10.3761/j.issn.0254-1769.2019.10.009
|
|
Tang F, Zhu XM, Lu Y, et al. Nursing care for patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy[J]. Chin J Nurs, 2019, 54(10):1495-1498.
|
| [8] |
刘嘉龙, 郭文超, 滕娇, 等. 成人急性肾损伤患者连续性肾脏替代治疗管理的最佳证据总结[J]. 中华急危重症护理杂志, 2024, 5(2):172-180.
|
|
Liu JL, Guo WC, Teng J, et al. Summary of best evidence on the management of continuous renal replacement therapy in adult patients with acute kidney injury[J]. Chin J Crit Care Nurs, 2024, 5(2):172-180.
|
| [9] |
中国研究型医院学会生物治疗学专委会. CAR T细胞治疗NHL毒副作用临床管理专家共识[J]. 转化医学杂志, 2021, 10(1):1-11.
|
|
Biotherapeutics Committee of Chinese Research Hospital Asso-ciation. Experts consensus on clinical management of toxicity associated with CAR T cell therapy in non-Hodgkin’s lympho-ma(NHL)[J]. Transl Med J, 2021, 10(1):1-11.
|
| [10] |
花京剩, 张剑, 陈苏宁, 等. CAR-T细胞技术在复发或难治急性淋巴细胞白血病中的临床应用进展[J]. 临床血液学杂志, 2020, 33(1):78-82.
|
|
Hua JS, Zhang J, Chen SN, et al. Advances in clinical appli-cation of CAR-T cell technique in relapsed or refractory acute lymphoblastic leukemia[J]. J Clin Hematol, 2020, 33(1):78-82.
|
